6 unknown, 2 completed, 2 not yet recruiting. 10 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Unknown 6, Completed 2, Not yet recruiting 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Chemotherapeutic Toxicity: new trials by email Literature Review of Chemotherapeutic Toxicity trials Research Report on Chemotherapeutic Toxicity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer herombopag - Thrombopenia, Cervical Cancer | Phase 2 | Not yet recruiting | Peking University Cancer Hospital & Institute | 30 | 2025-01-01 | 2024-12-20 |
| Semaglutide in Auto-HSCT Semaglutide Pen Injector [Ozempic], Placebo - Intestinal Mucositis, Inflammation | Phase 2 | Not yet recruiting | Klaus Gottlob Müller | 40 | 2024-08-12 | 2024-06-10 |
| Coenzyme Q10 and Chemotherapeutic Toxicity in Breast Cancer Patients Placebo, Coenzyme Q10 200mg twice daily - Breast Cancer, Chemotherapeutic Toxicity | Phase 2 | Completed | Damanhour University | 40 | 2024-08-01 | 2025-12-26 |
| The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer Docetaxel, Prednisolone Acetate, Platinum-based drugs - Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency | Phase 2 | Unknown | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 50 | 2022-07-01 | 2022-10-24 |
| Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer Xinmailong Injection - Breast Neoplasms, Cardiac Event | Phase 2 | Unknown | Peking Union Medical College | 60 | 2019-01-01 | 2020-01-22 |
| Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy Gabapentin 300mg - Invasive Breast Cancer, Chemotherapeutic Toxicity | Phase 2 / Phase 3 | Unknown | British Columbia Cancer Agency | 46 | 2018-07-02 | 2018-06-25 |
| A Study of Apatinib Treatment in for Advanced Ovarian Cancer Apatinib, Taxus + platinum - Ovarian Cancer, Chemotherapeutic Toxicity | Phase 2 | Unknown | The People's Hospital of Leshan | 34 | 2017-08-01 | 2018-01-16 |
| Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer Apatinib plus XELOX - Chemotherapy Effect, Chemotherapeutic Toxicity | Phase 2 | Unknown | Shanghai Zhongshan Hospital | 35 | 2017-02-01 | 2019-06-28 |
| Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy - PIPAC - Peritoneum; Carcinomatosis, Peritoneal Neoplasms | Phase 2 | Completed | Michael Bau Mortensen | 143 | 2016-12-01 | 2022-10-07 |
| Intraperitoneal and System Chemotherapy Versus XELOX as First-line Chemotherapy for mCRC Irinotecan, Oxaliplatin, Capecitabine - Colorectal Cancer Metastatic, Chemotherapy Effect | Phase 2 | Unknown | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 100 | 2016-01-01 | 2019-01-03 |
Breast Neoplasms (2) · Arthralgia (1) · Cardiovascular Diseases (1) · Inflammation (1) · Myalgia (1) · Ovarian Neoplasms (1) · Peritoneal Neoplasms (1) · Radiation Injuries (1) · Stomach Neoplasms (1) · Thrombocytopenia (1) · Uterine Cervical Neoplasms (1)
Neoplasms (6) · Neoplasms by Site (6) · Breast Diseases (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Pathological Conditions, Signs and Symptoms (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2)
Oxaliplatin (2) · apatinib (2) · Capecitabine (1) · Cisplatin (1) · Docetaxel (1) · Doxorubicin (1) · Gabapentin (1) · Irinotecan (1) · Platinum (1) · XELOX (1) · coenzyme Q10 (1) · prednisolone acetate (1) · semaglutide (1) · ubiquinol (1) · xinmailong (1)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (2) · British Columbia Cancer Agency (1) · Damanhour University (1) · Klaus Gottlob Müller (1) · Michael Bau Mortensen (1) · Peking Union Medical College (1) · Peking University Cancer Hospital & Institute (1) · Shanghai Zhongshan Hospital (1) · The People's Hospital of Leshan (1)
China (6) · Denmark (1) · Egypt (1)
Ahmed Ashour, PhD (1) · Amira B Kassem, PhD (1) · Gehad Hassoub, Bachelor (1) · Hongqian Guo (1) · Jing Jing (1) · Noha Ahmed El Bassiouny, PhD (1) · Xiaofan Li, Dr (1) · Yasser Abdelkader (1)
PMID 19144680, PMID 20110050, PMID 2110385, PMID 26187614, PMID 29248399, PMID 29622384, PMID 30156363, PMID 30764783, PMID 30911656, PMID 30911669, PMID 30915164, PMID 33632264, PMID 35382819, PMID 39384243, PMID 42401951, PMID 8201386, PMID 9043028